What is schizophrenia Anees Bahji

Schizophrenia was first identified
more than a century ago,

but we still don’t know its exact causes.

It remains one of the most misunderstood
and stigmatized illnesses today.

So, let’s walk through what we do know—
from symptoms to causes and treatments.

Schizophrenia is considered a syndrome,

which means it may encompass
a number of related disorders

that have similar symptoms
but varying causes.

Every person with schizophrenia
has slightly different symptoms,

and the first signs can be easy to miss—
subtle personality changes, irritability,

or a gradual encroachment
of unusual thoughts.

Patients are usually diagnosed
after the onset of psychosis,

which typically occurs in the late teens
or early twenties for men

and the late twenties
or early thirties for women.

A first psychotic episode can feature
delusions, hallucinations,

and disordered speech and behavior.

These are called positive symptoms,

meaning they occur
in people with schizophrenia

but not in the general population.

It’s a common misperception
that people with schizophrenia

have multiple personalities,

but these symptoms indicate a disruption
of thought processes,

rather than the manifestation
of another personality.

Schizophrenia also has negative symptoms,

these are qualities that are reduced
in people with schizophrenia,

such as motivation,
expression of emotion, or speech.

There are cognitive symptoms as well,
like difficulty concentrating,

remembering information,
and making decisions.

So what causes the onset of psychosis?

There likely isn’t one single cause,
but a combination

of genetic and environmental
risk factors that contribute.

Schizophrenia has some of the strongest
genetic links of any psychiatric illness.

Though about 1% of people
have schizophrenia,

children or siblings of people
with schizophrenia are ten times likelier

to develop the disease,

and an identical twin
of someone with schizophrenia

has a 40% chance of being affected.

Often, immediate relatives
of people with schizophrenia

exhibit milder versions of traits
associated with the disorder—

but not to an extent
that requires treatment.

Multiple genes almost certainly
play a role,

but we don’t know how many, or which ones.

Environmental factors like exposure
to certain viruses in early infancy

might increase the chance
that someone will develop schizophrenia,

and use of some drugs,
including marijuana,

may trigger the onset of psychosis

in highly susceptible individuals.

These factors don’t affect
everyone the same way.

For those with very low genetic risk,

no amount of exposure
to environmental risk factors

will lead them to develop schizophrenia;

for those with very high risk, moderate
additional risk might tip the balance.

The antipsychotic drugs used to treat
schizophrenia have helped researchers

work backwards to trace signatures
of the disorder in the brain.

Traditional antipsychotics
block dopamine receptors.

They can be very effective
in reducing positive symptoms,

which are linked to an excess of dopamine
in particular brain pathways.

But the same drugs
can make negative symptoms worse,

and we’ve found that negative symptoms
of schizophrenia may be tied

to too little dopamine
in other brain areas.

Some people with schizophrenia
show a loss of neural tissue,

and it’s unclear whether this atrophy
is a result of the disease itself

or drug-induced suppression of signaling.

Fortunately, newer generations
of antipsychotics aim to address

some of these issues by targeting
multiple neurotransmitters,

like serotonin in addition to dopamine.

It’s clear that no one transmitter system
is responsible for all symptoms,

and because these drugs affect signaling
throughout the brain and body,

they can have other
side effects like weight gain.

In spite of these complications,
antipsychotics can be very effective,

especially when combined
with other interventions

like cognitive-behavioral therapy.

Electroconvulsive therapy, though
it provides relatively short-lived relief,

is also re-emerging
as an effective treatment,

especially when other options
have failed.

Early intervention
is also extremely important.

After months or years
of untreated psychosis,

certain psychoses can become embedded
in someone’s personality.

And yet, the dehumanizing stigma
attached to this diagnosis

can prevent people from seeking help.

People with schizophrenia
are often perceived as dangerous,

but are actually much more likely
to be the victims of violence

than the perpetrators.

And proper treatment may help reduce
the likelihood of violence

associated with schizophrenia.

That’s why education— for patients,
their families, and their communities—

helps erode the stigma
and improves access to treatment.

精神分裂症在一个
多世纪前首次被发现,

但我们仍然不知道其确切原因。

它仍然是当今最被误解
和污名化的疾病之一。

所以,让我们来看看我们所知道的——
从症状到原因和治疗。

精神分裂症被认为是一种综合征,

这意味着它可能
包含许多

具有相似症状
但原因不同的相关疾病。

每个精神分裂症患者的
症状都略有不同

,最初的迹象很容易被忽略——
细微的性格变化、

易怒或逐渐
出现不寻常的想法。

患者通常
在精神病发作后被诊断出来,

这通常发生在

男性的十
几岁或二十出头,女性的二十多岁或三十出头。

第一次精神病发作可能以
妄想、幻觉

和言语和行为紊乱为特征。

这些被称为阳性症状,

这意味着它们发生
在精神分裂症患者身上,

但不会发生在普通人群中。

精神分裂症患者具有多重人格是一种常见的误解

但这些症状表明
思维过程的中断,

而不是
另一种人格的表现。

精神分裂症也有负面症状,

这些
是精神分裂症患者的品质降低,

例如动机、
情感表达或言语。

还有认知症状,
例如难以集中注意力、

记忆信息
和做出决定。

那么是什么导致了精神病的发作呢?

可能不是一个单一的原因,
而是

遗传和环境
风险因素的结合。

精神分裂症
与任何精神疾病都有一些最强的遗传联系。

尽管大约 1% 的人
患有精神分裂症,但精神分裂症患者的

孩子或兄弟

姐妹患这种疾病的可能性是其十倍,

而精神分裂症患者的同卵双胞胎

有 40% 的机会受到影响。

通常,
精神分裂症患者的直系亲属

表现出与该疾病相关的较温和的特征——


并不需要治疗。

几乎可以肯定多个基因
在起作用,

但我们不知道有多少或哪些基因。

婴儿早期接触某些病毒等环境因素

可能会增加
某人患精神分裂症的机会,

而使用某些药物(
包括大麻)

可能会引发

高度易感个体的精神病发作。

这些因素不会
以同样的方式影响每个人。

对于那些遗传风险非常低的人

,再多的
接触环境风险因素

也不会导致他们患上精神分裂症;

对于那些风险非常高的人,适度的
额外风险可能会打破平衡。

用于治疗精神分裂症的抗精神病药
物帮助研究

人员逆向追踪
大脑中这种疾病的特征。

传统的抗精神病药会
阻断多巴胺受体。

它们可以非常有效
地减少阳性症状,

这些症状与
特定大脑通路中的多巴胺过量有关。

但同样的药物
会使阴性症状恶化

,我们发现
精神分裂症的阴性症状可能与

其他大脑区域的多巴胺过少有关。

一些精神分裂症患者
表现出神经组织的损失

,目前尚不清楚这种萎缩
是疾病本身的结果

还是药物诱导的信号抑制。

幸运的是,新一代
的抗精神病药物旨在

通过靶向多种神经递质来解决其中的一些问题

例如血清素和多巴胺。

很明显,没有一种传递系统
会导致所有症状,

而且由于这些药物会影响
整个大脑和身体的信号传导,

它们可能会产生其他
副作用,例如体重增加。

尽管存在这些并发症,但
抗精神病药仍然非常有效,

尤其是
与认知行为疗法等其他干预措施结合使用时

电惊厥疗法
虽然提供了相对短暂的缓解,但


作为一种有效的治疗方法重新出现,

尤其是在其他
选择失败时。

早期干预
也非常重要。

经过数月或数
年未经治疗的精神病,

某些精神病可能会
嵌入某人的个性中。

然而,
这种诊断所带来的非人道耻辱

会阻止人们寻求帮助。

精神分裂症
患者通常被认为是危险的,

但实际上比施暴者更有
可能成为暴力的受害者

适当的治疗可能有助于减少与精神分裂症相关
的暴力的可能性

这就是为什么教育——针对患者、
他们的家人和他们的社区——

有助于
消除污名并改善获得治疗的机会。